Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Inhibiting calpain 1 and 2 in cyclin G associated kinase–knockout mice mitigates podocyte injury
Xuefei Tian, Kazunori Inoue, Yan Zhang, Ying Wang, C. John Sperati, Christopher E. Pedigo, Tingting Zhao, Meihua Yan, Marwin Groener, Dennis G. Moledina, Karen Ebenezer, Wei Li, Zhenhai Zhang, Dan A. Liebermann, Lois Greene, Peter Greer, Chirag R. Parikh, Shuta Ishibe
Xuefei Tian, Kazunori Inoue, Yan Zhang, Ying Wang, C. John Sperati, Christopher E. Pedigo, Tingting Zhao, Meihua Yan, Marwin Groener, Dennis G. Moledina, Karen Ebenezer, Wei Li, Zhenhai Zhang, Dan A. Liebermann, Lois Greene, Peter Greer, Chirag R. Parikh, Shuta Ishibe
View: Text | PDF
Research Article Cell biology Nephrology

Inhibiting calpain 1 and 2 in cyclin G associated kinase–knockout mice mitigates podocyte injury

  • Text
  • PDF
Abstract

Evidence for reduced expression of cyclin G associated kinase (GAK) in glomeruli of patients with chronic kidney disease was observed in the Nephroseq human database, and GAK was found to be associated with the decline in kidney function. To examine the role of GAK, a protein that functions to uncoat clathrin during endocytosis, we generated podocyte-specific Gak-knockout mice (Gak-KO), which developed progressive proteinuria and kidney failure with global glomerulosclerosis. We isolated glomeruli from the mice carrying the mutation to perform messenger RNA profiling and unearthed evidence for dysregulated podocyte calpain protease activity as an important contributor to progressive podocyte damage. Treatment with calpain inhibitor III specifically inhibited calpain-1/-2 activities, mitigated the degree of proteinuria and glomerulosclerosis, and led to a striking increase in survival in the Gak-KO mice. Podocyte-specific deletion of Capns1, essential for calpain-1 and calpain-2 activities, also improved proteinuria and glomerulosclerosis in Gak-KO mice. Increased podocyte calpain activity–mediated proteolysis of IκBα resulted in increased NF-κB p65–induced expression of growth arrest and DNA-damage-inducible 45 beta in the Gak-KO mice. Our results suggest that loss of podocyte-associated Gak induces glomerular injury secondary to calcium dysregulation and aberrant calpain activation, which when inhibited, can provide a protective role.

Authors

Xuefei Tian, Kazunori Inoue, Yan Zhang, Ying Wang, C. John Sperati, Christopher E. Pedigo, Tingting Zhao, Meihua Yan, Marwin Groener, Dennis G. Moledina, Karen Ebenezer, Wei Li, Zhenhai Zhang, Dan A. Liebermann, Lois Greene, Peter Greer, Chirag R. Parikh, Shuta Ishibe

×

Figure 6

Podocyte deletion of Capns1 improves glomerulosclerosis and kidney failure in Gak-KO mice.

Options: View larger image (or click on image) Download as PowerPoint
Podocyte deletion of Capns1 improves glomerulosclerosis and kidney failu...
(A) Calpain-1/-2 activities in primary podocytes isolated from control (green), Capns1-KO (red), Gak-KO (blue), and Gak/Capns1-DKO (black) mice at P14. n = 7. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (B) Calpain-1/-2 activities in urine samples from control (green), Capns1-KO (red), Gak-KO (blue), and Gak/Capns1-DKO (black) mice at 3 weeks of age and 5 weeks of age. n = 7. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (C) Quantification of urine albumin/creatinine ratio at 1, 2, 4, and 8 weeks of age from control (green), Capns1-KO (red), Gak-KO (blue), and Gak/Capns1-DKO (black) mice. n = 7 as shown on the graph. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (D) Plasma creatinine levels at 3, 5, and 7 weeks of age from control (green), Capns1-KO (red), Gak-KO (blue), and Gak/Capns1-DKO (black) mice. n = 6. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (E) Body weight at 1, 2, 3, 4, 6, and 8 weeks of age from control (green), Capns1-KO (red), Gak-KO (blue), and Gak/CapnS1-DKO (black) mice. n = 21. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (F) Survival curves from control (green), Capns1-KO (red), Gak-KO (blue), and Gak/Capns1-DKO (black) mice. n = 19. (G) Representative light microscopy images (H&E) from control, Capns1-KO, Gak-KO, and Gak/CAPNS1-DKO mice kidneys at 7 weeks of age. Scale bar: 25 μm. (H) Quantification of glomerulosclerosis in G. n = 4. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (I) Representative trichrome staining from control, Capns1-KO, Gak-KO, and Gak/Capns1-DKO mouse kidneys at 7 weeks of age. Scale bar: 100 μm. (J) Quantification of tubulointerstitial injuries in I. n = 4. *P < 0.05 vs. control mice; #P < 0.05 vs. Gak-KO mice. (K) Representative TEM images from control, Capns1-KO, Gak-KO, and Gak/Capns1-DKO mouse kidneys at 5 weeks of age. Scale bar: 1 μm. (L) Quantification of foot processes in K. n = 4 mice per group; 15 capillary tufts of glomeruli for each mouse were evaluated. (A–E, H, J, and L) Statistically analyzed via a 1-way ANOVA with Dunnett’s correction.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts